Edwards Lifesciences Sells Surgical Unit

Edwards Lifesciences Corp. in Irvine said Monday that it completed the sale of a surgical-services unit to a German company, Fresenius Medical Care, for $45 million in cash.

The “perfusion unit,” Cardiovascular Resources Inc. in San Diego, provides hospitals with clinicians who operate heart-lung machines during open-heart surgery.

Edwards’ stock climbed to a 52-week high of $27.10 before closing Monday at $26.30, up 6 cents a share, on the New York Stock Exchange. Bloomberg News